Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Overview
Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Discounted Cash Flow
DCF Analysis for RVPHW.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.39
Current Fair Value
$0.39
↑ 12990.0% Upside
Undervalued by 12990.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison